Pulmonary haemorrhagic syndromes in children
Identifieur interne : 000146 ( Istex/Corpus ); précédent : 000145; suivant : 000147Pulmonary haemorrhagic syndromes in children
Auteurs : A. Avital ; C. Springer ; S. GodfreySource :
- Paediatric Respiratory Reviews [ 1526-0542 ] ; 2000.
English descriptors
- KwdEn :
- Teeft :
- Airway, Alveolar haemorrhage, Alveolar macrophages, Alveolar walls, Arteriovenous, Arteriovenous malformation, Arteriovenous malformations, Blood cells, Bronchial arteries, Bronchial circulation, Bronchoalveolar lavage, Chloroquine, Chloroquine cytotoxic drugs, Congenital anomalies, Corticosteroid, Cystic fibrosis, Cytology iron index, Diffuse, Diffuse alveolar haemorrhage, Diffuse haemorrhage, Diffusion capacity, Embolization, Foreign body, Fungal infection, Gastrointestinal tract, Hadassah university hospital, Haemoptysis, Haemorrhage, Haemosiderosis, Harcourt publishers, Hereditary haemorrhagic telangiectasia, Idiopathic, Invasive aspergillosis, Iron deficiency anaemia, Macrophage, Malformation, Massive haemoptysis, Older children, Open lung biopsy, Pediatr pulmonol, Pediatric idiopathic, Pulmonary fibrosis, Pulmonary haemorrhage, Pulmonary hemosiderosis, Pulmonary hypertension, Pulmonary venous hypertension, Recurrent episodes, Renal involvement, Respiratory tract, Respiratory tract infection, Such cases, Syndrome, Systemic lupus erythematosis, Vasculitis, Young children.
Abstract
Abstract: Pulmonary haemorrhage in children is rare and may be either focal or diffuse, idiopathic or associated with an underlying disease. Focal bleeding is usually associated with congenital anomalies or localized acquired disease. Many of the disorders causing diffuse alveolar haemorrhage appear to be immunologically mediated. Treatment modalities include management of the underlying disease and the use of corticosteroids, chloroquine and/or cytotoxic drugs and induce remission in more than half of the patients with diffuse haemorrhage.
Url:
DOI: 10.1053/prrv.2000.0058
Links to Exploration step
ISTEX:E17512C49C466AFB63AFCD8D864D311230C37065Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pulmonary haemorrhagic syndromes in children</title><author><name sortKey="Avital, A" sort="Avital, A" uniqKey="Avital A" first="A." last="Avital">A. Avital</name><affiliation><mods:affiliation>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</mods:affiliation></affiliation></author><author><name sortKey="Springer, C" sort="Springer, C" uniqKey="Springer C" first="C." last="Springer">C. Springer</name><affiliation><mods:affiliation>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</mods:affiliation></affiliation></author><author><name sortKey="Godfrey, S" sort="Godfrey, S" uniqKey="Godfrey S" first="S." last="Godfrey">S. Godfrey</name><affiliation><mods:affiliation>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:E17512C49C466AFB63AFCD8D864D311230C37065</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1053/prrv.2000.0058</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-79NVV0B6-B/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000146</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000146</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Pulmonary haemorrhagic syndromes in children</title><author><name sortKey="Avital, A" sort="Avital, A" uniqKey="Avital A" first="A." last="Avital">A. Avital</name><affiliation><mods:affiliation>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</mods:affiliation></affiliation></author><author><name sortKey="Springer, C" sort="Springer, C" uniqKey="Springer C" first="C." last="Springer">C. Springer</name><affiliation><mods:affiliation>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</mods:affiliation></affiliation></author><author><name sortKey="Godfrey, S" sort="Godfrey, S" uniqKey="Godfrey S" first="S." last="Godfrey">S. Godfrey</name><affiliation><mods:affiliation>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Paediatric Respiratory Reviews</title><title level="j" type="abbrev">YPRRV</title><idno type="ISSN">1526-0542</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000">2000</date><biblScope unit="volume">1</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="266">266</biblScope><biblScope unit="page" to="273">273</biblScope></imprint><idno type="ISSN">1526-0542</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1526-0542</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>pulmonary bleeding, paediatric</term></keywords><keywords scheme="Teeft" xml:lang="en"><term>Airway</term><term>Alveolar haemorrhage</term><term>Alveolar macrophages</term><term>Alveolar walls</term><term>Arteriovenous</term><term>Arteriovenous malformation</term><term>Arteriovenous malformations</term><term>Blood cells</term><term>Bronchial arteries</term><term>Bronchial circulation</term><term>Bronchoalveolar lavage</term><term>Chloroquine</term><term>Chloroquine cytotoxic drugs</term><term>Congenital anomalies</term><term>Corticosteroid</term><term>Cystic fibrosis</term><term>Cytology iron index</term><term>Diffuse</term><term>Diffuse alveolar haemorrhage</term><term>Diffuse haemorrhage</term><term>Diffusion capacity</term><term>Embolization</term><term>Foreign body</term><term>Fungal infection</term><term>Gastrointestinal tract</term><term>Hadassah university hospital</term><term>Haemoptysis</term><term>Haemorrhage</term><term>Haemosiderosis</term><term>Harcourt publishers</term><term>Hereditary haemorrhagic telangiectasia</term><term>Idiopathic</term><term>Invasive aspergillosis</term><term>Iron deficiency anaemia</term><term>Macrophage</term><term>Malformation</term><term>Massive haemoptysis</term><term>Older children</term><term>Open lung biopsy</term><term>Pediatr pulmonol</term><term>Pediatric idiopathic</term><term>Pulmonary fibrosis</term><term>Pulmonary haemorrhage</term><term>Pulmonary hemosiderosis</term><term>Pulmonary hypertension</term><term>Pulmonary venous hypertension</term><term>Recurrent episodes</term><term>Renal involvement</term><term>Respiratory tract</term><term>Respiratory tract infection</term><term>Such cases</term><term>Syndrome</term><term>Systemic lupus erythematosis</term><term>Vasculitis</term><term>Young children</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Pulmonary haemorrhage in children is rare and may be either focal or diffuse, idiopathic or associated with an underlying disease. Focal bleeding is usually associated with congenital anomalies or localized acquired disease. Many of the disorders causing diffuse alveolar haemorrhage appear to be immunologically mediated. Treatment modalities include management of the underlying disease and the use of corticosteroids, chloroquine and/or cytotoxic drugs and induce remission in more than half of the patients with diffuse haemorrhage.</div></front></TEI><istex><corpusName>elsevier</corpusName><keywords><teeft><json:string>haemorrhage</json:string><json:string>pulmonary haemorrhage</json:string><json:string>haemoptysis</json:string><json:string>idiopathic</json:string><json:string>haemosiderosis</json:string><json:string>macrophage</json:string><json:string>chloroquine</json:string><json:string>diffuse alveolar haemorrhage</json:string><json:string>malformation</json:string><json:string>airway</json:string><json:string>corticosteroid</json:string><json:string>vasculitis</json:string><json:string>embolization</json:string><json:string>arteriovenous</json:string><json:string>cystic fibrosis</json:string><json:string>bronchial circulation</json:string><json:string>blood cells</json:string><json:string>syndrome</json:string><json:string>massive haemoptysis</json:string><json:string>alveolar haemorrhage</json:string><json:string>arteriovenous malformation</json:string><json:string>diffuse haemorrhage</json:string><json:string>bronchial arteries</json:string><json:string>bronchoalveolar lavage</json:string><json:string>diffuse</json:string><json:string>renal involvement</json:string><json:string>alveolar macrophages</json:string><json:string>hadassah university hospital</json:string><json:string>respiratory tract infection</json:string><json:string>systemic lupus erythematosis</json:string><json:string>gastrointestinal tract</json:string><json:string>pulmonary hypertension</json:string><json:string>recurrent episodes</json:string><json:string>young children</json:string><json:string>pulmonary fibrosis</json:string><json:string>respiratory tract</json:string><json:string>alveolar walls</json:string><json:string>diffusion capacity</json:string><json:string>hereditary haemorrhagic telangiectasia</json:string><json:string>fungal infection</json:string><json:string>older children</json:string><json:string>pulmonary venous hypertension</json:string><json:string>foreign body</json:string><json:string>iron deficiency anaemia</json:string><json:string>such cases</json:string><json:string>harcourt publishers</json:string><json:string>cytology iron index</json:string><json:string>chloroquine cytotoxic drugs</json:string><json:string>arteriovenous malformations</json:string><json:string>congenital anomalies</json:string><json:string>open lung biopsy</json:string><json:string>invasive aspergillosis</json:string><json:string>pulmonary hemosiderosis</json:string><json:string>pediatric idiopathic</json:string><json:string>pediatr pulmonol</json:string></teeft></keywords><author><json:item><name>A. Avital</name><affiliations><json:string>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</json:string></affiliations></json:item><json:item><name>C. Springer</name><affiliations><json:string>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</json:string></affiliations></json:item><json:item><name>S. Godfrey</name><affiliations><json:string>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>pulmonary bleeding, paediatric</value></json:item></subject><arkIstex>ark:/67375/6H6-79NVV0B6-B</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>Miscellaneous</json:string></originalGenre><abstract>Abstract: Pulmonary haemorrhage in children is rare and may be either focal or diffuse, idiopathic or associated with an underlying disease. Focal bleeding is usually associated with congenital anomalies or localized acquired disease. Many of the disorders causing diffuse alveolar haemorrhage appear to be immunologically mediated. Treatment modalities include management of the underlying disease and the use of corticosteroids, chloroquine and/or cytotoxic drugs and induce remission in more than half of the patients with diffuse haemorrhage.</abstract><qualityIndicators><score>6.964</score><pdfWordCount>4052</pdfWordCount><pdfCharCount>27732</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>8</pdfPageCount><pdfPageSize>576 x 790 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractWordCount>76</abstractWordCount><abstractCharCount>546</abstractCharCount><keywordCount>1</keywordCount></qualityIndicators><title>Pulmonary haemorrhagic syndromes in children</title><pmid><json:string>12531089</json:string></pmid><pii><json:string>S1526-0542(00)90058-7</json:string></pii><genre><json:string>article</json:string></genre><host><title>Paediatric Respiratory Reviews</title><language><json:string>unknown</json:string></language><publicationDate>2000</publicationDate><issn><json:string>1526-0542</json:string></issn><pii><json:string>S1526-0542(00)X0010-3</json:string></pii><volume>1</volume><issue>3</issue><pages><first>266</first><last>273</last></pages><genre><json:string>journal</json:string></genre></host><namedEntities><unitex><date><json:string>2000</json:string><json:string>1919</json:string></date><geogName></geogName><orgName><json:string>Hebrew University</json:string><json:string>RESEARCH DIRECTIONS</json:string><json:string>Harcourt Publishers Ltd</json:string><json:string>Institute of Pulmonology, Hadassah University Hospital, POB</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>C. Springer</json:string><json:string>A. Avital</json:string></persName><placeName><json:string>Jerusalem</json:string><json:string>Israel</json:string><json:string>Cleveland</json:string></placeName><ref_url><json:string>http://www.idealibrary.com</json:string></ref_url><ref_bibl><json:string>Saeed et al.</json:string><json:string>Boat et al.</json:string><json:string>Chryssanthopoulos et al.</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/6H6-79NVV0B6-B</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - respiratory system</json:string><json:string>2 - pediatrics</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - respiratory system</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Pulmonary and Respiratory Medicine</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Pediatrics, Perinatology, and Child Health</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2000</publicationDate><copyrightDate>2000</copyrightDate><doi><json:string>10.1053/prrv.2000.0058</json:string></doi><id>E17512C49C466AFB63AFCD8D864D311230C37065</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-79NVV0B6-B/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-79NVV0B6-B/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/6H6-79NVV0B6-B/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Pulmonary haemorrhagic syndromes in children</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://scientific-publisher.data.istex.fr">ELSEVIER</publisher><availability><licence><p>elsevier</p></licence></availability><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M"></p><date>2000</date></publicationStmt><notesStmt><note type="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note><note type="content">Section title: SERIES: RARE CHRONIC LUNG DISEASE</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Pulmonary haemorrhagic syndromes in children</title><author xml:id="author-0000"><persName><forename type="first">A.</forename><surname>Avital</surname></persName><note type="correspondence"><p>Correspondence to: Dr. A. Avital, Institute of Pulmonology, Hadassah University Hospital, POB 12000, Jerusalem 91120, Israel.</p></note><affiliation>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</affiliation></author><author xml:id="author-0001"><persName><forename type="first">C.</forename><surname>Springer</surname></persName><affiliation>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</affiliation></author><author xml:id="author-0002"><persName><forename type="first">S.</forename><surname>Godfrey</surname></persName><affiliation>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</affiliation></author><idno type="istex">E17512C49C466AFB63AFCD8D864D311230C37065</idno><idno type="ark">ark:/67375/6H6-79NVV0B6-B</idno><idno type="DOI">10.1053/prrv.2000.0058</idno><idno type="PII">S1526-0542(00)90058-7</idno></analytic><monogr><title level="j">Paediatric Respiratory Reviews</title><title level="j" type="abbrev">YPRRV</title><idno type="pISSN">1526-0542</idno><idno type="PII">S1526-0542(00)X0010-3</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000"></date><biblScope unit="volume">1</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="266">266</biblScope><biblScope unit="page" to="273">273</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2000</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Abstract: Pulmonary haemorrhage in children is rare and may be either focal or diffuse, idiopathic or associated with an underlying disease. Focal bleeding is usually associated with congenital anomalies or localized acquired disease. Many of the disorders causing diffuse alveolar haemorrhage appear to be immunologically mediated. Treatment modalities include management of the underlying disease and the use of corticosteroids, chloroquine and/or cytotoxic drugs and induce remission in more than half of the patients with diffuse haemorrhage.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>pulmonary bleeding, paediatric</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2000">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-79NVV0B6-B/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType><istex:document><converted-article version="4.5.2" docsubtype="mis" xml:lang="en"><item-info><jid>YPRRV</jid><aid>90058</aid><ce:pii>S1526-0542(00)90058-7</ce:pii><ce:doi>10.1053/prrv.2000.0058</ce:doi><ce:copyright type="other" year="2000"></ce:copyright></item-info><head><ce:dochead><ce:textfn>SERIES: RARE CHRONIC LUNG DISEASE</ce:textfn></ce:dochead><ce:title>Pulmonary haemorrhagic syndromes in children</ce:title><ce:author-group><ce:author><ce:given-name>A.</ce:given-name><ce:surname>Avital</ce:surname><ce:cross-ref refid="FNUN1"><ce:sup>f1</ce:sup><ce:footnote id="FNUN1"><ce:label>f1</ce:label><ce:note-para>Correspondence to: Dr. A. Avital, Institute of Pulmonology, Hadassah University Hospital, POB 12000, Jerusalem 91120, Israel.</ce:note-para></ce:footnote></ce:cross-ref></ce:author><ce:author><ce:given-name>C.</ce:given-name><ce:surname>Springer</ce:surname></ce:author><ce:author><ce:given-name>S.</ce:given-name><ce:surname>Godfrey</ce:surname></ce:author><ce:affiliation><ce:textfn>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</ce:textfn></ce:affiliation></ce:author-group><ce:abstract><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para>Pulmonary haemorrhage in children is rare and may be either focal or diffuse, idiopathic or associated with an underlying disease. Focal bleeding is usually associated with congenital anomalies or localized acquired disease. Many of the disorders causing diffuse alveolar haemorrhage appear to be immunologically mediated. Treatment modalities include management of the underlying disease and the use of corticosteroids, chloroquine and/or cytotoxic drugs and induce remission in more than half of the patients with diffuse haemorrhage.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords><ce:section-title>Keywords</ce:section-title><ce:keyword><ce:text>pulmonary bleeding, paediatric</ce:text></ce:keyword></ce:keywords></head></converted-article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Pulmonary haemorrhagic syndromes in children</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Pulmonary haemorrhagic syndromes in children</title></titleInfo><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Avital</namePart><affiliation>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</affiliation><description>Correspondence to: Dr. A. Avital, Institute of Pulmonology, Hadassah University Hospital, POB 12000, Jerusalem 91120, Israel.</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Springer</namePart><affiliation>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Godfrey</namePart><affiliation>Institute of Pulmonology, Hadassah University Hospital and Hadassah-Hebrew University Medical School, Jerusalem, Israel</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="Miscellaneous" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">2000</dateIssued><copyrightDate encoding="w3cdtf">2000</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><abstract lang="en">Abstract: Pulmonary haemorrhage in children is rare and may be either focal or diffuse, idiopathic or associated with an underlying disease. Focal bleeding is usually associated with congenital anomalies or localized acquired disease. Many of the disorders causing diffuse alveolar haemorrhage appear to be immunologically mediated. Treatment modalities include management of the underlying disease and the use of corticosteroids, chloroquine and/or cytotoxic drugs and induce remission in more than half of the patients with diffuse haemorrhage.</abstract><note type="content">Section title: SERIES: RARE CHRONIC LUNG DISEASE</note><subject lang="en"><genre>Keywords</genre><topic>pulmonary bleeding, paediatric</topic></subject><relatedItem type="host"><titleInfo><title>Paediatric Respiratory Reviews</title></titleInfo><titleInfo type="abbreviated"><title>YPRRV</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">2000</dateIssued></originInfo><identifier type="ISSN">1526-0542</identifier><identifier type="PII">S1526-0542(00)X0010-3</identifier><part><date>2000</date><detail type="volume"><number>1</number><caption>vol.</caption></detail><detail type="issue"><number>3</number><caption>no.</caption></detail><extent unit="issue-pages"><start>209</start><end>306</end></extent><extent unit="pages"><start>266</start><end>273</end></extent></part></relatedItem><identifier type="istex">E17512C49C466AFB63AFCD8D864D311230C37065</identifier><identifier type="ark">ark:/67375/6H6-79NVV0B6-B</identifier><identifier type="DOI">10.1053/prrv.2000.0058</identifier><identifier type="PII">S1526-0542(00)90058-7</identifier><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</recordContentSource></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-79NVV0B6-B/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000146 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000146 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:E17512C49C466AFB63AFCD8D864D311230C37065
|texte= Pulmonary haemorrhagic syndromes in children
}}
| This area was generated with Dilib version V0.6.33. |  |